Intellia Therapeutics, Inc. (NTLA)

13.13 -0.14 (-1.06%) USD  |  NASDAQ  |  Apr 02, 16:00
13.12 -0.01 (-0.08%) After-Hours: 20:00
More

Intellia Therapeutics EBIT (% of Annual Revenues)

EBIT (% of Annual Revenues) Chart

View EBIT (% of Annual Revenues) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (% of Annual Revenues) Range, Past 5 Years

View EBIT (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (% of Annual Revenues) Benchmarks

View EBIT (% of Annual Revenues) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Personalis, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade